STRONGBRIDGE BIOPHARMA plc Intangible Assets, Net (Excluding Goodwill)
STRONGBRIDGE BIOPHARMA plc had Intangible Assets, Net (Excluding Goodwill) of $17.58 million as of 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2021-08-05
- 2021-06-30: Intangible Assets, Net (Excluding Goodwill) $17.58M.
- 2021-03-31: Intangible Assets, Net (Excluding Goodwill) $18.83M.
- 2020-12-31: Intangible Assets, Net (Excluding Goodwill) $20.09M.
- 2020-09-30: Intangible Assets, Net (Excluding Goodwill) $21.34M.
| Period end | Intangible Assets, Net (Excluding Goodwill) |
|---|---|
| 2021-06-30 | $17.58M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $18.83M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $20.09M 10-Q · filed 2021-08-05 |
| 2020-09-30 | $21.34M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $22.60M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $23.86M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $25.11M 10-K · filed 2021-03-03 |
| 2019-09-30 | $26.37M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $27.62M 10-Q · filed 2019-07-31 |
| 2019-03-31 | $28.88M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $30.13M 10-K · filed 2020-02-28 |
| 2018-09-30 | $54.46M 10-Q · filed 2018-10-31 |
| 2018-06-30 | $56.17M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $58.04M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $35.16M 10-K · filed 2019-02-27 |
| 2017-09-30 | $36.41M 6-K · filed 2017-11-14 |
| 2017-06-30 | $58.39M 6-K · filed 2017-08-07 |
| 2017-03-31 | $59.64M 6-K · filed 2017-05-16 |
| 2016-12-31 | $60.90M 10-K · filed 2018-03-12 |
| 2015-12-31 | $36.55M 20-F · filed 2017-04-04 |